Log in or Sign up for Free to view tailored content for your specialty!
Lupus News
US Supreme Court decision on mifepristone ‘not a victory, but a punt’
On June 13, the U.S. Supreme Court rejected a lawsuit that challenged the FDA’s approach to regulating the abortion pill mifepristone.
Belimumab triggers ‘surge’ of memory B cells in patients with lupus
Belimumab substantially increases circulating memory B-cells in patients with systemic lupus erythematosus, potentially enabling “a more efficient targeting of the B-cell compartment,” according to data published in Rheumatology.
Log in or Sign up for Free to view tailored content for your specialty!
Juvenile Arthritis Awareness Month encourages children to be #StrongerThanJA
Juvenile arthritis can impact the physical and emotional wellbeing of children in unique ways, manifesting in loneliness and depression, according to the Arthritis Foundation.
Nearly one-quarter of all SARDs outpatient visits in US result in opioid prescription
Nearly one-quarter of outpatient visits by patients with systemic autoimmune rheumatic diseases in the United States between 2006 and 2019 resulted in an opioid prescription, according to data published in Arthritis Care & Research.
‘Earlier use of biologics’ like belimumab may improve long-term lupus outcomes
Early use of biologics like belimumab may limit complications associated with steroid use and improve long-term outcomes in systemic lupus erythematosus, according to data presented at the EULAR 2024 Congress.
Methylprednisolone exposure a significant risk factor for organ damage in pediatric lupus
Reducing steroids in favor of more targeted therapies can minimize organ damage in pediatric systemic lupus erythematosus, according to data presented at EULAR 2024 Congress.
Patient with lupus treated with KYV-101 CAR T-cell therapy relapses after 5 months
A patient with lupus nephritis treated with KYV-101, a chimeric antigen receptor T-cell immunotherapy, saw their disease return 5 months after initially showing a response to the treatment, according to the manufacturer.
Higher steroid dose improves lupus nephritis renal outcomes, raises mortality risk
Patients with lupus nephritis who receive higher initial doses of glucocorticoids demonstrate improved renal outcomes, albeit with increased serious infection and mortality risks, according to data published in Arthritis & Rheumatology.
‘Very important’: Belimumab decreases lupus flare vs placebo in early, established disease
Treatment with belimumab resulted in fewer flares in patients with either early or established systemic lupus erythematosus, especially among those with no baseline organ damage, according to data presented at the EULAR 2024 Congress.
Lab results, symptom tracking top list of key metrics among rheumatology patients
The ability to view laboratory results, track symptoms and sharing them with a provider were rated as the most useful potential app functions by patients with rheumatic and musculoskeletal diseases, according to data.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read